PLX
Protalix BioTherapeutics, Inc. (DE) Common Stock (PLX)
$70
About Protalix BioTherapeutics, Inc. (DE) Common Stock (PLX)
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Details
Daily high
$2.72
Daily low
$2.66
Price at open
$2.68
52 Week High
$3.19
52 Week Low
$1.60
Market cap
216.7M
Dividend yield
-
Volume
1.2M
Avg. volume
770,302
P/E ratio
11.85
Protalix BioTherapeutics, Inc. (DE) Common Stock News
Details
Daily high
$2.72
Daily low
$2.66
Price at open
$2.68
52 Week High
$3.19
52 Week Low
$1.60
Market cap
216.7M
Dividend yield
-
Volume
1.2M
Avg. volume
770,302
P/E ratio
11.85